clinical trials

The real-world evidence project at the FDA adds Syapse to its list of partners in a push past trial boundaries
The real-world evidence project at the FDA adds Syapse to its list of partners in a push past trial boundaries
Endpoints
FDA
Syapse
EHRs
clinical trials
RWE
real world evidence
Flag link:
Ailing Mallinckrodt's drug for rare, life-threatening renal condition clears pivotal study
Ailing Mallinckrodt's drug for rare, life-threatening renal condition clears pivotal study
Endpoints
Mallinckrodt
clinical trials
hepatorenal syndrome
terlipressin
Flag link:
Treating glioblastoma with a Ziopharm drug and IL-12 gene therapy
Treating glioblastoma with a Ziopharm drug and IL-12 gene therapy
Fierce Biotech
Ziopharm Oncology
IL-12
gene therapy
glioblastoma
clinical trials
Flag link:
$60M B round to propel Landos through Phase II IBD trials
$60M B round to propel Landos through Phase II IBD trials
BioCentury
Landos Biopharma
clinical trials
ulcerative colitis
Crohn's Disease
BT-11
Flag link:
AZ/MSD’s PARP inhibitor shows promise as first-line ovarian cancer treatment
AZ/MSD’s PARP inhibitor shows promise as first-line ovarian cancer treatment
Pharmaforum
AstraZeneca
Merck
Lynparza
clinical trials
advanced ovarian cancer
ovarian cancer
Calquence
Flag link:
Deciphera soars as phase 3 cancer data tee up FDA filing
Deciphera soars as phase 3 cancer data tee up FDA filing
Fierce Biotech
Deciphera
clinical trials
ripretinib
gastrointestinal stromal tumors
Flag link:
Experts Seek Tweaks to FDA Draft Guidance on Clinical Trial Diversity
Experts Seek Tweaks to FDA Draft Guidance on Clinical Trial Diversity
RAPS.org
FDA
clinical trials
diversity
real world data
real world evidence
RWE
RWD
Flag link:
Sesen Bio reports data update from phase 3 trial for high-risk non-muscle invasive bladder cancer
Sesen Bio reports data update from phase 3 trial for high-risk non-muscle invasive bladder cancer
Pharmaceutical Business Review
Sesen Bio
clinical trials
Vicinium
bladder cancer
Flag link:
89Bio starting Proof of Concept Trial for NASH therapy and announcing expansion of leadership team
89Bio starting Proof of Concept Trial for NASH therapy and announcing expansion of leadership team
CP WIre
89Bio
NASH
NAFLD
clinical trials
Flag link:
89Bio starting Proof of Concept Trial for NASH therapy and announcing expansion of leadership team
89Bio
NASH
NAFLD
clinical trials
Flag link:
Allakos sustains its gains on strength of GI readout
Allakos sustains its gains on strength of GI readout
BioCentury
Alllakos
clinical trials
eosinophilic gastritis
AK002
Flag link:
Astellas pushes non-hormonal menopause drug into phase 3
Astellas pushes non-hormonal menopause drug into phase 3
Pharmaforum
Astellas
menopause
clinical trials
fezolinetant
Flag link:
AstraZeneca, Merck herald PhIII prostate cancer win for Lynparza — overtaking Clovis, J&J in PARP race
AstraZeneca, Merck herald PhIII prostate cancer win for Lynparza — overtaking Clovis, J&J in PARP race
Endpoints
Lynparza
AstraZeenca
Merck
prostate cancer
clinical trials
Flag link:
Rhythm’s genetic obesity drug hits primary endpoint in phase 3
Rhythm’s genetic obesity drug hits primary endpoint in phase 3
Fierce Biotech
Rhythm Pharmaceuticals
genetic obesity
clinical trials
setmelanotide
Flag link:
Amid rising concern, pay-to-play clinical trials are drawing federal scrutiny
Amid rising concern, pay-to-play clinical trials are drawing federal scrutiny
Stat
clinical trials
pay-to-play
Flag link:
Sanofi ends partnership with Lexicon after trial failure
Sanofi ends partnership with Lexicon after trial failure
In-Pharma Technologist
Sanofi
Lexicon Pharmaceuticals
clinical trials
Zynquista
diabetes
Flag link:
Racing after the leaders, Eli Lilly's migraine drug clears another pivotal study
Racing after the leaders, Eli Lilly's migraine drug clears another pivotal study
Endpoints
Eli Lilly
Emgality
clinical trials
migraines
chronic migraine
episodic migraine
Flag link:
SillaJen, Transgene fall with latest oncolytic virus setback
SillaJen, Transgene fall with latest oncolytic virus setback
BioCentury
Transgene
SillaJen
clinical trials
Pexa-Vec
oncolytic viruses
Flag link:
Medicines Co. awaits its date with destiny
Medicines Co. awaits its date with destiny
Biopharma Dive
The Medicines Company
clinical trials
inclisiran
Flag link:
Novartis' Kisqali sharpens survival edge with second ph3 win
Novartis' Kisqali sharpens survival edge with second ph3 win
Fierce Pharma
Novartis
Kisqali
breast cancer
clinical trials
Flag link:

Pages